Should I buy or sell KORU Medical Systems stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for KORU Medical Systems in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KRMD shares. View KRMD analyst ratings or view top-rated stocks .

What is KORU Medical Systems' stock price target for 2024?

4 equities research analysts have issued 12-month price objectives for KORU Medical Systems' stock. Their KRMD share price targets range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.50 in the next year. This suggests a possible upside of 69.9% from the stock's current price. View analysts price targets for KRMD or view top-rated stocks among Wall Street analysts .

How have KRMD shares performed in 2024?

KORU Medical Systems' stock was trading at $2.46 at the beginning of 2024. Since then, KRMD stock has decreased by 16.3% and is now trading at $2.06. View the best growth stocks for 2024 here .

Are investors shorting KORU Medical Systems?

KORU Medical Systems saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,050,000 shares, an increase of 5.6% from the March 15th total of 994,500 shares. Based on an average trading volume of 95,500 shares, the short-interest ratio is currently 11.0 days. View KORU Medical Systems' Short Interest .

When is KORU Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our KRMD earnings forecast .

How were KORU Medical Systems' earnings last quarter?

KORU Medical Systems, Inc. (NASDAQ:KRMD) announced its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The business had revenue of $7.19 million for the quarter, compared to analysts' expectations of $7.01 million. KORU Medical Systems had a negative trailing twelve-month return on equity of 27.82% and a negative net margin of 48.18%.

What guidance has KORU Medical Systems issued on next quarter's earnings?

KORU Medical Systems issued an update on its FY 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31.2 million-$32.2 million, compared to the consensus revenue estimate of $32.3 million.

What other stocks do shareholders of KORU Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other KORU Medical Systems investors own include NVIDIA (NVDA) , Enphase Energy (ENPH) , Alibaba Group (BABA) , Walt Disney (DIS) , PennyMac Financial Services (PFSI) , Inseego (INSG) , Micron Technology (MU) , Advanced Micro Devices (AMD) , Marvell Technology (MRVL) and Taiwan Semiconductor Manufacturing (TSM) .

How do I buy shares of KORU Medical Systems?

Shares of KRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:KRMD

KORU Medical Systems (KRMD) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free KRMD Stock Alerts

$2.06

-0.06 (-2.83%)

(As of 04:00 PM ET)

Compare

Today's Range: $2.05
▼
$2.15
50-Day Range: $2.04
▼
$2.49
52-Week Range: $1.98
▼
$4.48

Volume: 61,319 shs
Average Volume: 96,070 shs
Market Capitalization: $94.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.50

Get KORU Medical Systems alerts:

KORU Medical Systems MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 69.9% Upside
$3.50 Price Target
Short Interest: Bearish
2.30% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.14
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.15) to ($0.09) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.99 out of 5 stars

Medical Sector

569th out of 919 stocks

Surgical & Medical Instruments Industry

60th out of 93 stocks

3.5

Analyst's Opinion

Consensus Rating
KORU Medical Systems has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
KORU Medical Systems has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
2.30% of the outstanding shares of KORU Medical Systems have been sold short.
Short Interest Ratio / Days to Cover
KORU Medical Systems has a short interest ratio ("days to cover") of 11, which indicates bearish sentiment.
Change versus previous month
Short interest in KORU Medical Systems has recently increased by 5.58%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
KORU Medical Systems does not currently pay a dividend.
Dividend Growth
KORU Medical Systems does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for KRMD.

2.9

News and Social Media Coverage

News Sentiment
KORU Medical Systems has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for KORU Medical Systems this week, compared to 1 article on an average week.
MarketBeat Follows
Only 1 people have added KORU Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, KORU Medical Systems insiders have not sold or bought any company stock.
Percentage Held by Insiders
25.60% of the stock of KORU Medical Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
58.60% of the stock of KORU Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for KORU Medical Systems are expected to grow in the coming year, from ($0.15) to ($0.09) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of KORU Medical Systems is -7.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of KORU Medical Systems is -7.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
KORU Medical Systems has a P/B Ratio of 4.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About KORU Medical Systems Stock (NASDAQ:KRMD)

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

KRMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KRMD Stock News Headlines

April 17, 2024 | finance.yahoo.com

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

April 16, 2024 | americanbankingnews.com

Short Interest in KORU Medical Systems, Inc. (NASDAQ:KRMD) Expands By 5.6%

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 11, 2024 | businesswire.com

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

April 9, 2024 | americanbankingnews.com

KORU Medical Systems (NASDAQ:KRMD) Shares Down 1%

March 28, 2024 | investorplace.com

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

March 18, 2024 | businesswire.com

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

March 17, 2024 | msn.com

Yankees get the World Series-winning crew back together to help out in spring training

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 16, 2024 | finance.yahoo.com

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2023 Earnings Call Transcript

March 15, 2024 | finance.yahoo.com

KORU Medical Systems Full Year 2023 Earnings: EPS Misses Expectations

March 14, 2024 | msn.com

Saratoga County Sheriff’s Office to participate in statewide STOP-DWI St. Patrick’s Day campaign

March 14, 2024 | markets.businessinsider.com

Buy Rating Justified: REPRO-MED Systems’ Strong Growth Prospects and Solid Financial Performance

March 14, 2024 | finance.yahoo.com

KORU Medical Systems Inc (KRMD) Reports Mixed 2023 Financial Results and Provides 2024 Outlook

March 13, 2024 | finance.yahoo.com

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

March 12, 2024 | benzinga.com

Earnings Outlook For KORU Medical Systems

March 11, 2024 | businesswire.com

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

March 8, 2024 | markets.businessinsider.com

Craig-Hallum Keeps Their Buy Rating on REPRO-MED Systems (KRMD)

March 6, 2024 | markets.businessinsider.com

Buy Rating Affirmed for KORU Medical Systems Amidst Growth and Market Expansion Prospects

March 6, 2024 | businesswire.com

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

February 28, 2024 | morningstar.com

KORU Medical Systems Inc KRMD

February 21, 2024 | finance.yahoo.com

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

February 21, 2024 | businesswire.com

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

February 16, 2024 | finance.yahoo.com

Retail investors account for 39% of KORU Medical Systems, Inc.'s (NASDAQ:KRMD) ownership, while institutions account for 32%

January 18, 2024 | msn.com

Saratoga County Sheriff’s Deputies honored as Deputy of the Year

December 13, 2023 | markets.businessinsider.com

Buy Rating for KORU Medical Systems Amid Growth and Market Expansion Opportunities

November 29, 2023 | finance.yahoo.com

KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference

See More Headlines

Receive KRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KORU Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/13/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:KRMD
CUSIP: N/A
CIK: 704440
Web: www.korumedical.com
Phone: (845) 469-2042
Fax: 845-469-5518
Employees: 82
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $3.50
High Stock Price Target: $4.00
Low Stock Price Target: $3.00
Potential Upside/Downside: +65.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.29)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-13,740,000.00
Net Margins: -48.18%
Pretax Margin: -34.27%
Return on Equity: -27.82%
Return on Assets: -21.30%

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 4.55
Quick Ratio: 3.77

Sales & Book Value

Annual Sales: $28.52 million
Price / Sales: 3.40
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.45 per share
Price / Book: 4.71

Miscellaneous

Outstanding Shares: 45,710,000
Free Float: 34,008,000
Market Cap: $96.91 million
Optionable: Optionable
Beta: 0.53

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Ms. Linda M. Tharby (Age 56)
President, CEO & Director
Comp: $962.6k
Mr. Thomas Adams (Age 51)
CFO, Secretary & Treasurer
Comp: $381.9k
Mr. Brian Case (Age 51)
Chief Technology Officer
Comp: $356.31k
Mr. Christopher Pazdan
Senior Vice President of Operations
Mr. Rob Cannon
Vice President of Sales
Mr. Kenneth Miller (Age 55)
Chief Commercial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

KRMD Stock Analysis - Frequently Asked Questions

Should I buy or sell KORU Medical Systems stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for KORU Medical Systems in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KRMD shares.
View KRMD analyst ratings or view top-rated stocks.
What is KORU Medical Systems' stock price target for 2024?: 4 equities research analysts have issued 12-month price objectives for KORU Medical Systems' stock. Their KRMD share price targets range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.50 in the next year. This suggests a possible upside of 69.9% from the stock's current price.
View analysts price targets for KRMD or view top-rated stocks among Wall Street analysts.
How have KRMD shares performed in 2024?: KORU Medical Systems' stock was trading at $2.46 at the beginning of 2024. Since then, KRMD stock has decreased by 16.3% and is now trading at $2.06.
View the best growth stocks for 2024 here.
Are investors shorting KORU Medical Systems?: KORU Medical Systems saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,050,000 shares, an increase of 5.6% from the March 15th total of 994,500 shares. Based on an average trading volume of 95,500 shares, the short-interest ratio is currently 11.0 days.
View KORU Medical Systems' Short Interest.
When is KORU Medical Systems' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our KRMD earnings forecast.

How were KORU Medical Systems' earnings last quarter?: KORU Medical Systems, Inc. (NASDAQ:KRMD) announced its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The business had revenue of $7.19 million for the quarter, compared to analysts' expectations of $7.01 million. KORU Medical Systems had a negative trailing twelve-month return on equity of 27.82% and a negative net margin of 48.18%.
What guidance has KORU Medical Systems issued on next quarter's earnings?: KORU Medical Systems issued an update on its FY 2024 earnings guidance on Wednesday, March, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31.2 million-$32.2 million, compared to the consensus revenue estimate of $32.3 million.
What other stocks do shareholders of KORU Medical Systems own?: Based on aggregate information from My MarketBeat watchlists, some companies that other KORU Medical Systems investors own include NVIDIA (NVDA), Enphase Energy (ENPH), Alibaba Group (BABA), Walt Disney (DIS), PennyMac Financial Services (PFSI), Inseego (INSG), Micron Technology (MU), Advanced Micro Devices (AMD), Marvell Technology (MRVL) and Taiwan Semiconductor Manufacturing (TSM).
How do I buy shares of KORU Medical Systems?: Shares of KRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KRMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

KORU Medical Systems (KRMD) Stock Price, News & Analysis

KORU Medical Systems MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About KORU Medical Systems Stock (NASDAQ:KRMD)

KRMD Stock Price History

KRMD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

KRMD Stock Analysis - Frequently Asked Questions

Overall MarketRank^™